Abstract
In this issue of Cancer Cell, Espinosa-Carrasco etal. show that the efficacy of cancer immunotherapies depends upon the formation of intratumoral immune triads between antigen-presenting cells and antigen-specific CD4+ and CD8+ Tcells. This interaction reprograms tumor-specific CD8+ Tcells to exert potent effector functions and eradicate established solid tumors.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
